Plan-Optimization Method for Central-shielding Pelvic Volumetric-modulated Arc Therapy for Cervical Cancer

Ryuta Hirai1, Tomoaki Tamaki2,3, Mitsunobu Igari2

  • 1Department of Radiation Oncology, Saitama Medical University International Medical Center, Saitama, Japan rhirai@saitama-med.ac.jp.

In Vivo (Athens, Greece)
|November 4, 2020
PubMed
Summary

This study introduces an optimized volumetric-modulated arc therapy (VMAT) plan for cervical cancer using central shielding (CS). The optimized VMAT plan significantly reduces rectal dose while maintaining target coverage, comparable to 3DCRT.

Related Concept Videos